|
|
| |
|
|
| |
Overview
"Our state-of-the-art infrastructure for R&D and manufacturing gives us capacity and technological flexibility." -
Atin Tomar,
Scientific Manager, Biologics
Leveraging the India advantage, Syngene continues to incrementally invest in manufacturing and research infrastructure to meet growing global demand for partnered services along the drug value chain. We have the capabilities to rapidly conceptualize, execute and commission custom research laboratories and diverse/flexible large-scale manufacturing facilities to support our
international partnerships.
|
|
| |
|
|
|
|
